The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.

Source:http://linkedlifedata.com/resource/pubmed/id/12692538

Download in:

View as

General Info

PMID
12692538